No connection

Search Results

Analysis Neutral

Spyre CEO Sells $740K in Stock After 300% Surge as Key Q3 Data Nears

Apr 08, 2026 11:18 UTC

Key PointsThe CEO of Spyre Therapeutics reported selling 15,000 shares for a total transaction value of about $740,000 on April 1, 2026..

  • April 08, 2026 — 07:18 am EDT Written byJonathan PoncianoforThe Motley Fool-> The CEO of Spyre Therapeutics reported selling 15,000 shares for a total transaction value of about $740,000 on April 1, 2026
  • The transaction represented 2
  • 33% of Cameron Turtle’s directly held common stock holdings and reduced direct ownership to 627,540 common shares post-sale, as reported in the Form 4

April 08, 2026 — 07:18 am EDT Written byJonathan PoncianoforThe Motley Fool-> The CEO of Spyre Therapeutics reported selling 15,000 shares for a total transaction value of about $740,000 on April 1, 2026. The transaction represented 2.33% of Cameron Turtle’s directly held common stock holdings and reduced direct ownership to 627,540 common shares post-sale, as reported in the Form 4. No indirect holdings or derivative securities were involved; all shares transacted were directly held common stock. Cameron Turtle, the chief executive officer ofSpyre Therapeutics(NASDAQ:SYRE), reported the direc

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile